Plexus is estimated to be undervalued by about 8% following its issuance of fiscal 2026 guidance that projects more than 20% revenue growth, with continued expansion and margin improvement expected in 2027. The most followed narrative points to a fair value of $293.25 per share, compared with the latest close of $270.35, driven by a revenue mix shift toward higher-margin healthcare, life sciences, aerospace, and defense sectors. However, the stock trades at a price-to-earnings ratio of 39 times, above a fair ratio of 29 times and the US Electronic industry average of 31.8 times, leaving less room if growth or margins disappoint. Key risks include heavy customer concentration and cyclicality in semiconductor capital equipment and aerospace.
Plexus CorpIssued fiscal 2026 guidance projecting >20% revenue growth and margin improvement, with fair value estimate 8% above current price.
